The University of Chicago Header Logo

A phase II trial of UFT and leucovorin in women 65 years and older with advanced breast cancer.

A phase II trial of UFT and leucovorin in women 65 years and older with advanced breast cancer. Am J Clin Oncol. 2005 Feb; 28(1):65-9.

View in: PubMed